A systematic review and meta-analysis to help define the optimal approach for lobectomy for non-small cell lung cancer was undertaken. Articles comparing thoracotomy (open), multi-port Video-assisted thoracic surgery (mVATS), robotic VATS (rVATS), and uniportal VATS (uVATS) were scrutinized and evidence-based statements using the American College of Cardiology/American Heart Association clinical practice guideline recommendations made.
2 Questions Does VATS result in similar lymph node evaluation and pathological upstaging when compared to open lobectomy? What is the optimal MIS approach for lymph node evaluation and pathological upstaging? Statements 5. Open lobectomy results in an increase in nodal upstaging when compared to mVATS. Class IIA (Level C-LD) 6. mVATS, uVATS, and rVATS may be equivalent in terms of number of lymph nodes harvested and nodal upstaging.
Class IIB (Level B-NR)
See Tables 3 to 5 2
Questions
In patients requiring adjuvant therapy, will VATS allow more patients to receive and then complete planned chemotherapy, compared to open lobectomy? See Tables 3 and 4 2
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